A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial
Clinical trial NCT02057380 · COMPLETED
Trial details
- NCT number
- NCT02057380
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-16
- Primary completion
- 2016-10-14
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.